According to the general belief about the cardiomyopathy, there is the increase in the size of the heart due to certain pathologies that are playing their part in it. Hence, there are many ways that are devised for the treatment of this condition. But these can be seen when the patients are getting the best treatment possible for this condition. According to the researchers at Miami Miller School of Medicine’s Interdisciplinary Stem Cell institute, there is another milestone that has been achieved for the treatment of this condition. The FDA has approved about this, and hence, soon this treatment will be available in the hospitals which are very much useful for the greater proportion of the world. There has been one clinical trial that has been going on in the very same research institute in which the patients can be treated with either the Autologous cells or with the donor cells for the treatment of dilated cardiomyopathy.